계정 가입
이미 존재한 계정
가입을 클릭하여 코인타임의 <a class="underline" href="#term-of-service">서비스 약관</a> 과 a class="underline" href="#privacy-policy">개인정보 보호 정책</a> . 에 동의함.
email 로 로그인
email 로 가입
사용자 이메일
수신함을 확인하세요
중의 링크를 통해 로그인 하세요
중의 링크를 통해 가입 하세요
Altiris Therapeutics
company
About
Altiris Therapeutics develops and commercializes drugs to treat metastatic cancer.
- 501 - 1000
Highlights
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- $35M
- Industries
- Biotechnology,Health Care,Medical,Therapeutics
- Founded date
- Jan 1, 2005
- Number Of Employee
- 501 - 1000
- Operating Status
- Active
Altiris Therapeutics develops and commercializes drugs to treat metastatic cancer. The company offers CXCR4 receptor, which acts as a mediator of cellular and chemical trafficking; and Emtriva, which is used for the treatment of HIV Infection.Altiris Therapeutics was founded in 2005 and is based in Atlanta, Georgia.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$35M
Altiris Therapeutics has raised a total of
$35M
in funding over 2 rounds. Their latest funding was raised on
Oct 9, 2007 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Oct 9, 2007 | Series B | $35M | 2 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
2
Altiris Therapeutics is funded by 2 investors.
Centrosome Ventures
and Georgia Venture Partners
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
— | Series B |
Georgia Venture Partners
|
— | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
